Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a £1.74 million US-Ireland Research and Development Partnership grant.

4 Feb 2011

HHS encourages lower-cost drug usage to help reduce Medicaid spending

With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.

4 Feb 2011

CIGNA fourth quarter shareholders' net income increases to $461 million

CIGNA Corporation today reported shareholders' net income of $461 million, or $1.69 per share, for the fourth quarter of 2010 compared with shareholders' net income of $330 million, or $1.19 per share, for the fourth quarter of 2009.

3 Feb 2011

PEARS project reviews professional pharmacy education in Ireland

A research team from Aston University in Birmingham, UK has completed The Pharmacy Education and Accreditation Reviews Project (PEARS), which reviewed professional pharmacy education as a whole in Ireland. The Project was led by Professor Keith Wilson and Dr Chris Langley, who are based in the School of Life & Health Sciences at Aston.

3 Feb 2011

HealthCore, AstraZeneca collaborate to conduct real-world studies on disease states, treatment

AstraZeneca Pharmaceuticals LP and HealthCore, the health outcomes research subsidiary of WellPoint, today announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease.

3 Feb 2011

New research: Antioxidants in pecans may prevent development of various diseases

A new research study from Loma Linda University demonstrates that naturally occurring antioxidants in pecans may help contribute to heart health and disease prevention; the results are published in the January 2011 issue of The Journal of Nutrition.

2 Feb 2011

CorVel third quarter earnings per share increases 4% to $0.56

CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.

1 Feb 2011

McLeod Health joins SafetyConnect to effectively monitor clinical data and reduce infections

By eliminating piles of paper, McLeod Health is now able to more effectively monitor clinical data and reduce infections with the help of the Premier healthcare alliance's SafetyConnect™ program.

1 Feb 2011

PCMA finds Ohio's Medicaid program can save $135 million over the next decade

Ohio's Medicaid program could cost taxpayers an additional $1.6 billion next year, a 49 percent jump in the state's share of costs for the health care program covering more than 2 million poor and disabled Ohioans, according to new information released by the Governor's Office of Health Transformation.

1 Feb 2011

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

Offering the morning after pill free over the counter has not reduced the number of teenage pregnancies and may be associated with a rise in sexually-transmitted diseases (STIs), according to a report by experts at The University of Nottingham.

1 Feb 2011

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit Support Program for molecular diagnostic and genetic tests.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company's proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, in Miami, Florida.

29 Jan 2011

Healthcare at Home acquires Sciensus

Healthcare at Home Ltd, Europe's leading international provider of home-based healthcare and specialty pharmacy services, is today pleased to announce that it has acquired Sciensus Ltd, a provider of health informatics for clients across the NHS and the pharmaceutical industry.

27 Jan 2011

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

An unrestricted grant from Octapharma USA supported the development of a Continuing Education (CE) initiative entitled the "The Diagnosis and Management of von Willebrand Disease," a program of the National Home Infusion Association (NHIA).

25 Jan 2011

World's largest sterile compounding center for oncology patients

Health Robotics today announced the official opening and live operation of the largest Sterile Compounding Center for Oncology patients in the world. Akdeniz University Hospital in Antalya (Turkey) compounds 90% of its 80.000 annual chemotherapy intravenous doses with 4 CytoCare robots and related Health Robotics' technology, or an average of 325 patient doses per 6-hour work cycle.

25 Jan 2011

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

25 Jan 2011

College of Osteopathic Medicine receives grant to develop training program for medical students

Nova Southeastern University's medical school, the College of Osteopathic Medicine, recently received a $2.3 million federal grant to develop an academic curriculum to train medical and other students in the health professions to better meet the needs of patients in a changing national health care system.

24 Jan 2011

Bluecross awards UTHSC $2,912,751 grant to promote patient safety

The University of Tennessee Health Science Center has been awarded a $2,912,751 grant from the BlueCross BlueShield of Tennessee Health Foundation to fund its "Promoting Patient Safety Through Teamwork-Focused Interdisciplinary Simulations Program."

24 Jan 2011

Cancer Research UK launches new Centre in Glasgow

Cancer Research UK today (Thursday) launches a new Centre which will accelerate the pace of research in Glasgow and see the city become a world leader in the development of new treatments tailored for individual cancer patients.

21 Jan 2011

Pharmacy News and Research

Further Reading

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

HHS encourages lower-cost drug usage to help reduce Medicaid spending

CIGNA fourth quarter shareholders' net income increases to $461 million

PEARS project reviews professional pharmacy education in Ireland

HealthCore, AstraZeneca collaborate to conduct real-world studies on disease states, treatment

New research: Antioxidants in pecans may prevent development of various diseases

CorVel third quarter earnings per share increases 4% to $0.56

McLeod Health joins SafetyConnect to effectively monitor clinical data and reduce infections

PCMA finds Ohio's Medicaid program can save $135 million over the next decade

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Healthcare at Home acquires Sciensus

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

World's largest sterile compounding center for oncology patients

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

College of Osteopathic Medicine receives grant to develop training program for medical students

Bluecross awards UTHSC $2,912,751 grant to promote patient safety

Cancer Research UK launches new Centre in Glasgow

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News